We are pleased to share a selection of papers from the 2024 collection on the topic “Innovations in Pancreatic Cancer: Targeted Therapies and Precision Approaches”, published in the journal Cancers (ISSN: 2072-6694). Below is a list of high-quality articles that we believe you will find insightful and engaging.

1. “Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer”
by Xin Gu and Tamara Minko
Cancers 2024, 16(8), 1589; https://doi.org/10.3390/cancers16081589
Available online: https://www.mdpi.com/2072-6694/16/8/1589

2. “The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study”
by Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela and Ebubekir Daglilar
Cancers 2024, 16(9), 1625; https://doi.org/10.3390/cancers16091625
Available online: https://www.mdpi.com/2072-6694/16/9/1625

3. “Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer”
by Ingmar F. Rompen, Joseph R. Habib, Christopher L. Wolfgang and Ammar A. Javed
Cancers 2024, 16(3), 489; https://doi.org/10.3390/cancers16030489
Available online: https://www.mdpi.com/2072-6694/16/3/489

4. “Deep Learning Applications in Pancreatic Cancer”
by Hardik Patel, Theodoros Zanos and D. Brock Hewitt
Cancers 2024, 16(2), 436; https://doi.org/10.3390/cancers16020436  
Available online: https://www.mdpi.com/2072-6694/16/2/436

5. “The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma”
by Alexander A. Lekan and Louis M. Weiner
Cancers 2024, 16(3), 559; https://doi.org/10.3390/cancers16030559
Available online: https://www.mdpi.com/2072-6694/16/3/559

6. “Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges”
by Julianne M. Szczepanski, Mark A. Rudolf and Jiaqi Shi
Cancers 2024, 16(4), 794; https://doi.org/10.3390/cancers16040794
Available online: https://www.mdpi.com/2072-6694/16/4/794

7. “Evidence and Future Perspectives for Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Scoping Review”
by Yutaka Endo, Minoru Kitago and Yuko Kitagawa
Cancers 2024, 16(9), 1632; https://doi.org/10.3390/cancers16091632  
Available online: https://www.mdpi.com/2072-6694/16/9/1632

8. “Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian”
by Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, Jade Gambill, Diksha Mahendru, Chandler H. Park and Yan Leyfman
Cancers 2024, 16(13), 2329; https://doi.org/10.3390/cancers16132329  
Available online: https://www.mdpi.com/2072-6694/16/13/2329

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office